FBXO22 and neoplasm: Among the cancer types with a healthy sample number greater than ten, we observed high expression of FBXO22 in tissues from 14 tumor types (UCEC, ESCA, HNSC, KICH, READ, THCA, LIHC, KIRP, BLCA, BRCA, COAD, LUSC, STAD, and LUAD) compared with adjacent healthy tissues, but no significant difference in expression was observed in PRAD or KIRC (Figure 1A).